Elicio Therapeutics ELTX
NASDAQ ELTX
$1.67 +0.10 (+6.37%)
At close: Oct 21, 2026 · 4:00 PM EDT

Elicio Therapeutics (ELTX) Restructuring Costs (2022)

Updated

Elicio Therapeutics' Restructuring Costs came in at $3.15 million for Q4 2022, up 12.5% from the prior quarter.

Analysis

Elicio Therapeutics (ELTX) Restructuring Costs (2022) Analysis & Trends

For FY2022, Elicio Therapeutics' Restructuring Costs was $9.19 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Elicio Therapeutics 31.85 Mn -45.77 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 3.15 Mn
Sep 30, 2022 2.80 Mn
API Access

Elicio Therapeutics Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=ELTX&period=max&api_key=YOUR_API_KEY